Pioneer Teens: Safety & efficacy of oral semaglutide in children & adolescents with type 2 diabetes

• Research type

  Research Study

• Full title

  Efficacy and safety of oral semaglutide versus placebo both in combination with metformin and/or basal insulin in children and adolescents with type 2 diabetes

• IRAS ID

  1003439

• Contact name

  Timothy Barrett

• Contact email

  t.g.barrett@bham.ac.uk

• Eudract number

  2018-002952-34

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  20/YH/0291

• Date of REC Opinion

  28 Jan 2021

• REC opinion

  Further Information Favourable Opinion